# Phase 3 Imaging and Safety Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing SPECT Imaging

> **NCT00156793** · PHASE3 · COMPLETED · sponsor: **Acusphere** · enrollment: 400 (—)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **PROCEDURE:** AI-700 contrast-enhanced echocardiography

## Key facts

- **NCT ID:** NCT00156793
- **Lead sponsor:** Acusphere
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** 400 (—)
- **Last updated:** 2006-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00156793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00156793, "Phase 3 Imaging and Safety Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing SPECT Imaging". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00156793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*